(Q34108508)

31 July 2017

1 reference

title

Epstein-barr virus infection and multiple sclerosis: a review (English)

1 reference

31 July 2017

0 references

0 references

0 references

1

Alberto Ascherio

1 reference

31 July 2017

2

Kassandra L Munger

1 reference

31 July 2017

6 April 2010

1 reference

Journal of Neuroimmune Pharmacology

31 July 2017

1 reference

31 July 2017

5

1 reference

31 July 2017

3

1 reference

31 July 2017

271-277

1 reference

https://scigraph.springernature.com/pub.10.1007/s11481-010-9201-3

31 July 2017

0 references

cites work

A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9201-3

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9201-3

Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9201-3

Vitamin D intake and incidence of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9201-3

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9201-3

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11481-010-9201-3

Multiple Sclerosis After Infectious Mononucleosis

21 January 2018

1 reference

12 December 2020

Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults

1 reference

12 December 2020

Prevalence of Epstein-Barr virus in Japan: trends and future prediction

1 reference

12 December 2020

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

1 reference

12 December 2020

Selective association of multiple sclerosis with infectious mononucleosis.

1 reference

12 December 2020

Private specificities of CD8 T cell responses control patterns of heterologous immunity

1 reference

12 December 2020

Epstein-Barr virus and disease activity in multiple sclerosis

1 reference

12 December 2020

Characteristics of Hodgkin's Lymphoma after Infectious Mononucleosis

1 reference

12 December 2020

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

1 reference

12 December 2020

Spectrum of Epstein-Barr virus-associated diseases

1 reference

12 December 2020

Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children

1 reference

12 December 2020

EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis

1 reference

12 December 2020

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

1 reference

12 December 2020

Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis.

1 reference

12 December 2020

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

1 reference

12 December 2020

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

1 reference

12 December 2020

Epstein-Barr virus genotypes in multiple sclerosis

1 reference

12 December 2020

Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.

1 reference

12 December 2020

Epstein-Barr virus in pediatric multiple sclerosis

1 reference

12 December 2020

Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis

1 reference

12 December 2020

Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein

1 reference

12 December 2020

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis

1 reference

12 December 2020

Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

1 reference

12 December 2020

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

1 reference

12 December 2020

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

1 reference

12 December 2020

Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3.

1 reference

12 December 2020

A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk

1 reference

12 December 2020

Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis

1 reference

12 December 2020

Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis

1 reference

12 December 2020

Molecular epidemiology of Epstein-Barr virus infection

1 reference

12 December 2020

High seroprevalence of Epstein-Barr virus in children with multiple sclerosis

1 reference

12 December 2020

Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

1 reference

12 December 2020

The effect of infections on susceptibility to autoimmune and allergic diseases

1 reference

12 December 2020

An Epstein Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway

1 reference

12 December 2020

Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis

1 reference

12 December 2020

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

1 reference

12 December 2020

Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis

1 reference

12 December 2020

Plasma titers of antibodies against Epstein-Barr virus BZLF1 and risk of multiple sclerosis

1 reference

12 December 2020

Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis

1 reference

12 December 2020

Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen

1 reference

12 December 2020

Association of infectious mononucleosis with multiple sclerosis. A population-based study.

1 reference

12 December 2020

Multiple sclerosis in the Faroe Islands: an epitome

1 reference

12 December 2020

A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters

1 reference

12 December 2020

Variation in the Epstein-Barr virus receptor, CR2, and risk of multiple sclerosis

1 reference

12 December 2020

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain

1 reference

12 December 2020

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

1 reference

12 December 2020

Primary infection with the Epstein-Barr virus and risk of multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis and Epstein-Barr virus

1 reference

12 December 2020

Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries

1 reference

12 December 2020

Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls

1 reference

12 December 2020

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2

1 reference

12 December 2020

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

1 reference

12 December 2020

Epstein-Barr virus: exploiting the immune system

1 reference

12 December 2020

Early primary infection and high Epstein-Barr virus antibody titers in Greenland Eskimos at high risk for nasopharyngeal carcinoma

1 reference

12 December 2020

A randomized clinical trial of valacyclovir in multiple sclerosis

1 reference

12 December 2020

The enigmatic epidemiology of nasopharyngeal carcinoma

1 reference

12 December 2020

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

1 reference

12 December 2020

Migrant studies in multiple sclerosis

1 reference

12 December 2020

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

1 reference

12 December 2020

Environmental risk factors for multiple sclerosis. Part I: The role of infection

1 reference

12 December 2020

Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain

1 reference

12 December 2020

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

1 reference

12 December 2020

Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.

1 reference

12 December 2020

10.1007/S11481-010-9201-3

Identifiers

DOI

1 reference

PubMed ID

20369303

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

20369303